Fig. 2From: The conundrum of metaplastic breast cancer: a single Egyptian institution retrospective 10-year experience (2011–2020)a DFS for the whole metaplastic breast cancer cohort. b DFS according to the molecular subtype. c DFS according to the metaplastic pathological subtype. d DFS according to LVI. e DFS according to Ki-67(%). f DFS according to NACT. g DFS according to pT stageBack to article page